Vascular Solutions, Inc.Minneapolis, MN, United States (NASDAQ (GM): VASC)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Vascular Solutions Financial Statements

Vascular Solutions Financial Information

Company Type Public
Single Location
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Vascular Solutions Income Statement

  2007 2006 2005
Revenue ($ mil.) 52.9 43.3 32.8
Gross Profit ($ mil.) 32.0 29.1 23.4
Operating Income ($ mil.) (4.3) (1.7) (0.7)
Total Net Income ($ mil.) (4.3) (1.8) (0.6)
Diluted EPS (Net Income) (0.28) (0.12) (0.04)
More Vascular Solutions financial information

Vascular Solutions Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 15.2 14.1 14.4
Gross Profit ($ mil.) 9.7 9.3 6.4
Operating Income ($ mil.) (0.4) 0.3 0.5
Total Net Income ($ mil.) (0.5) 0.2 0.5
Diluted EPS (Net Income) (0.03) 0.01 0.04
More Vascular Solutions financial information

Vascular Solutions Stock Quote & Chart

10/10/08 14:58:06 EST • NASDAQ • 7.07 • Increased by +0.0400 • Increased by +0.5690 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Vascular Solutions Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.30 2.19 1.56
Price/Earnings Ratio 413.00 22.29 15.82
Price/Book Ratio 9.48 2.28 1.52
Price/Cash Flow Ratio -- 15.76 9.88
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Vascular Solutions Financial Ratios

Vascular Solutions Competitive Intelligence

Abbott Labs Boston Scientific Medtronic
Annual Sales ($ mil.) 25,914.2 8,357.0 13,515.0
Employees 68,000 27,500 --
Market Cap ($ mil.) 90,488.8 19,591.2 60,397.3

Competitive Landscape